Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07591610 · ClinicalTrials.gov registry record · NA
Perioperative High-flow Nasal Oxygen in Patients Undergoing Robotic Surgery
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 190
- Enrollment target
NCT07591610: Clinical Trial NA study, sponsored by Beth Israel Deaconess Medical Center.
NCT07591610 is a NA study that has not yet begun recruiting, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 190 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07591610, a NA study, has not yet begun recruiting, sponsored by Beth Israel Deaconess Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
Study Summary
The aim of the study is to assess whether perioperative use of high-flow nasal oxygen (HFNO) during the period from induction of anesthesia until discharge from the post-anesthesia care unit in patients undergoing robotic-assisted surgery reduces perioperative oxygen desaturation and postoperative pulmonary complications.
Primary Outcome
Incidence of desaturation between induction of anesthesia and discharge from PACU, measured as SpO2 \<92%
Interventions
- DEVICE High flow nasal oxygen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2029-10-31 |
| Phase | NA |
What is known before NCT07591610 opens enrollment
NCT07591610 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which High flow nasal oxygen is the first listed.
NCT07591610 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07591610 about?
NCT07591610 is a clinical study titled "Perioperative High-flow Nasal Oxygen in Patients Undergoing Robotic Surgery". The aim of the study is to assess whether perioperative use of high-flow nasal oxygen (HFNO) during the period from induction of anesthesia until discharge from the post-anesthesia care unit in patients undergoing robotic-assisted surgery reduces perioperative oxygen desaturation and postoperative p...
What is the current status of trial NCT07591610?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 190 participants. The study started on 2026-08-01. Estimated completion is 2029-10-31.
What interventions are being tested in trial NCT07591610?
The interventions under investigation include: High flow nasal oxygen (DEVICE).
Who is sponsoring clinical trial NCT07591610?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07591610's enrollment target sits among peer trials
190 574th of 2000 higher than 1,425 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI